Ryan Crow
Senior Vice President, Investor Relations
Replay available
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2025 Earnings Call
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q2 2025 earnings conference call, held 2025-08-01. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Leonard Schleifer
Board Co-Chair, Co-Founder, President and Chief Executive Officer
Dr. George Yancopoulos
Board Co-Chair, Co-Founder, President and Chief Scientific Officer
Marian McCourt
Executive Vice President of Commercial
Chris Fenimore
Executive Vice President and Chief Financial Officer
Tim Anderson
Analyst, Bank of America
Tyler Van Buren
Analyst, TD Cowan
Chris Schott
Analyst, J.P. Morgan
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Regeneron Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.183 -- 00:00:05.271 Welcome to the Regeneron Pharmaceuticals Second Quarter 2025 Earnings Conference Call. 00:00:05.271 -- 00:00:08.617 My name is Shannon, and I will be your operator for today's call. 00:00:08.617 -- 00:00:11.301 At this time, all participants are in a listening mode. 00:00:11.301 -- 00:00:14.025 Later, we will conduct a question and answer session. 00:00:14.025 -- 00:00:16.509 Please note that this conference call is being recorded. 00:00:16.509 -- 00:00:19.855 I will now turn the call over to Ryan Crow, Senior Vice President, Investor Relations. 00:00:19.855 -- 00:00:22.115 You may begin. 00:00:22.519 -- 00:00:26.301 Thank you, Shannon. Good morning, good afternoon, and good evening to everyone listening 00:00:26.301 -- 00:00:29.585 around the world. Thank you for your interest in Regeneron, and welcome to our second 00:00:29.585 -- 00:00:34.392 quarter 2025 earnings conference call. An archive and transcript of this call will be 00:00:34.392 -- 00:00:40.460 available on the Regeneron Investor Relations website shortly after our call concludes. 00:00:40.460 -- 00:00:46.087 Joining me on today's call are Dr. Leonard Schleifer, Board Co-Chair, Co-Founder, 00:00:46.087 -- 00:00:49.298 President, and Chief Executive Officer of Dr. 00:00:49.298 -- 00:00:54.645 George Yancopoulos, Board Co-Chair, Co-Founder, President, and Chief Scientific Officer, 00:00:54.645 -- 00:00:59.412 Marian McCourt, Executive Vice President of Commercial, and Chris Fenimore, Executive 00:00:59.412 -- 00:01:02.517 Vice President and Chief Financial Officer. 00:01:02.517 -- 00:01:07.624 After our prepared remarks, the remaining time will be available for Q&A. 00:01:07.624 -- 00:01:11.289 I would like to remind you that remarks made on today's call may include for...